The Impact of Cardiovascular Prevention on the Cost Benefit of Influenza Vaccination for Australian Adults aged 50 –64 years old

Increasing evidence suggests that influenza vaccination can reduce coronary heart disease (CHD) outcomes. CHD and influenza cause a significant burden among Australian adults aged 50 –64, however, vaccine coverage remains suboptimal. The National Immunisation Program (NIP) funds vaccinations in this group only for those at high risk. The aim of this study was to determine whether expanding the NIP to all adults aged 50–64 to prevent acute myocardial infarction (AMI) and resp iratory hospitalisations will be cost beneficial.
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: 561 Source Type: research